PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

PAR Capital Position and 2024 Raising Requirements, page-103

  1. 696 Posts.
    lightbulb Created with Sketch. 128
    imo it's still a value buy at these levels, the options may end up being worthless but they're not worthless now as you can realise their value by selling on market, i'd still participate down to 38c.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.